New integrase inhibitor GSK1265744 safe and well tolerated in eight studies

The investigational HIV integrase inhibitor GSK1265744 was well tolerated, with no notable safety concerns, in a meta-analysis of eight studies testing the drug as either a pill or a long-acting injection, researchers reported at the recent 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver.

http://www.aidsmap.com/New-integrase-inhibitor-GSK1265744-safe-and-well-tolerated-in-eight-studies/page/2771746/